project id: TCGA-BLCA; case submitter id: TCGA-GV-A3QH; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.9; rna integrity number: 8.6; age at index: 67; days to birth: -24681; days to death: 258; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1944; age at diagnosis: 24681; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage II; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 237.0; icd 10 code: C67.0; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Trigone of bladder; synchronous malignancy: No; tissue or organ of origin: Trigone of bladder; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; cigarettes per day: 0.547945205479452; pack years smoked: 10.0; is ffpe: false; composition: Not Reported; days to collection: 162; days to sample procurement: 0; initial weight: 120.0; portion submitter id: TCGA-GV-A3QH-01A-11; percent lymphocyte infiltration: 8.0; percent monocyte infiltration: 1.0; percent necrosis: 15.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 85.0; percent tumor nuclei: 80.0;